Literature DB >> 10190743

Lamivudine is safe and effective in fulminant hepatitis B.

T Santantonio, M Mazzola, G Pastore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190743     DOI: 10.1016/s0168-8278(99)80119-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  [Postexposure prevention after occupational exposure to HBV, HCV and HIV].

Authors:  U Sarrazin; R Brodt; C Sarrazin; S Zeuzem
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

2.  Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Kenichi Fukai; Makoto Arai; Fumio Imazeki; Akihiro Suzuki; Hiroshi Suzuki; Tomohito Sadahiro; Shigeto Oda; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

Review 3.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

4.  The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Shin Yasui; Koichiro Okitsu; Yutaka Yonemitsu; Shigeto Oda; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2010-07-09       Impact factor: 7.527

5.  Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Hiroshige Kojima; Tatsuo Kanda; Hiromitsu Saisho; Hiroyuki Hirasawa; Hiroshi Suzuki
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

6.  Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: a pilot study.

Authors:  Qing-Wei Du; Ji-Guang Ding; Qing-Feng Sun; Liang Hong; Fu-Jing Cai; Qing-Qing Zhou; Yang-He Wu; Rong-Quan Fu
Journal:  Med Sci Monit       Date:  2013-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.